Long-Term clinical efficacy of liraglutide for type 2 diabetes: real-world evidence and outcomes from Pakistan

Long-Term clinical efficacy of liraglutide for type 2 diabetes: real-world evidence and outcomes from Pakistan

Background Liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has demonstrated efficacy in improving glycemic control and promoting weight loss in clinical trials. However, real-world data from diverse populations, particularly from South Asia, are limited. The study aims to evaluate t...

Full description

Saved in:
Bibliographic Details
Main Authors: Muhammad Daoud Butt, Siew Chin Ong, Azra Rafiq, Nighat Batool, Rumana Saifi, Samina Yaseen, Irum Kaukab, Basit Ramzan
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Journal of Pharmaceutical Policy and Practice
Subjects:
Glucagon-like peptide (GLP-1)
diabetes mellitus type 2
clinical effectiveness
glycemic control
real-world data
Online Access:https://www.tandfonline.com/doi/10.1080/20523211.2024.2432462
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.tandfonline.com/doi/10.1080/20523211.2024.2432462

Similar Items